Fundraising Fox7G BioVentures
Venture capitalBurlingame · 5 people tracked
Find your way into 7G BioVentures
Sign up to see every warm intro you have to 7G BioVentures
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 7G BioVentures team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
7G BioVentures targets first-in-class life science innovations, backing scientists, clinicians, and entrepreneurs who translate breakthrough discoveries into life-saving products. The fund is led by partners with decades of life science investment experience and established track records, and it focuses its investment activity on the U.S., Canada, and Europe.
Source: firm website, verified Oct 13, 2026.
Team · 5 people
from the firm's website & public directories
What they invest in
from 12 of 18 portfolio companiesBiotech ×10Healthtech ×9Medical Devices ×7Deep Tech ×4Digital Health ×2
HQs:United States×8Switzerland×1
Investments · 18 tracked
founders shown can be your intro pathBy year:2025 · 12022 · 12021 · 12019 · 14 dated
Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications.
BiotechDeep TechDigital HealthMedical DevicesBasel, CH
Dr. Yves Dudal(CEO)Prof. Dr. Patrick Shahgaldian(CSO)
Aqualung Therapeutics is an early-stage therapeutics company developing a drug discovery platform and pipeline focused on advancing human health.
BiotechHealthtechMedical DevicesTucson, US
Joe G.N. Garcia(Executive Officer, Director)Joe G.N. "Skip" Garcia(Founder & Chief Executive Officer)Shawntela Martinez(Chief Financial Officer (Fractional))Augustine Choi(Chief Medical Officer (Fractional))Stan Miele(President)
Co-investorsFlorida Opportunity Fund
Clinical-stage biopharmaceutical company developing best-in-class aryl hydrocarbon receptor agonists.
BiotechEncino, US
Matthew Davidson(Executive Officer, Director)
BoardDennis Brown(Director)
Co-investorsTarnagulla Ventures
BBy manufactures a device that converts breast milk into shelf-stable powder while preserving its immunological properties, serving neonatal intensive care units seeking to reduce preparation time and milk waste.
HealthtechMedical DevicesNew York City, US
Vansh Langer
Co-investorsPioneerY CombinatorAtypical VenturesCathexis VenturesFriends Family CapitalGaingels+1 more
__Twitter.png)
BBy develops a condensed breast milk product and process that preserves bioactive immunological properties for hospital distribution.
BiotechHealthtechMedical DevicesChicago, US
BoardDr. Langer
Co-investorsBeresford VenturesOlima Ventures
Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium.
BiotechDeep TechHealthtechMedical Devices
Michael D. Webb(President & CEO, Board Member)Edward Parsons(Chief Operating Officer)inMichael W. Belin(Chief Medical Officer)
Co-investorsNew World Angels
A biopharmaceutical company developing a pipeline of long-acting therapeutic candidates, including GLP-1 receptor agonists, amylin DACRAs, a PYY receptor agonist, and a glucagon receptor agonist.
BiotechSaratoga, US
Mitragotri Mitragotri(Executive Officer, Director)Ravi Srinivasan(Executive Officer, Director)in
Co-investorsCerity Partners VenturesColorcon VenturesHikma VenturesSanofi VenturesJDRF T1D Fund
A clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.
BiotechHealthtechMedical Devices
Lu Han(Chief Executive Officer)Jiangtao Ren(Chief Scientific Officer)Yajin Ni(Chief Technology Officer)
Co-investorsDecheng Capital
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Mark Esposito(CSO, Co-Founder and Board Member)inYibin Kang(Chair, Scientific Advisory Board and Co-Founder)Kendall Mohler(Executive Officer, Director)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)in
Co-investorsBioAdvanceFoundation Venture Capital Group, LLC
Mesentech develops prostaglandin prodrugs aimed at musculoskeletal regeneration.
BiotechHealthtechVancouver
David Hyman(Executive Officer)Robert Norman Young(Executive Officer, Director)Jay Mohr(Director)David Dvorak(Director)Jonathan Polak(Executive Officer, Director, Promoter)
Co-investorsBeresford VenturesBoutique Venture PartnersWUTIF Capital
Optimeos develops a nanoparticle-based drug formulation and delivery platform (CINCs and LINCs) for complex biologics including mRNA, DNA, peptides, and proteins, targeting rare diseases, immunology, and metabolic conditions such as obesity.
BiotechDeep TechHealthtechPrinceton, US
Robert K. Prud'homme, PhD(Director)Bob Prud'homme(Leadership (PhD))Rob Pagels(Leadership (PhD))Chet Markwalter(Leadership (PhD))inShahram Hejazi(Leadership (PhD))inGregory Harriman(Leadership (MD))in
Co-investorsAnzu PartnersHatch BioFund
Persperion Diagnostics develops touch-based sweat sensing technology for diagnostic measurement.
Deep TechDigital HealthHealthtechMedical DevicesSan Diego, US
Joseph Wang(Executive Officer)Lu Yin(Executive Officer, Director)Xinyu Liu(Executive Officer)
BoardAshwin Pushpala(Director)inXuhui Shao(Director)in
Co-investorsCornucopian Capital ManagementFoothill VenturesSamsung NextEclipse Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AqualungCurbsideCurbsidehealthEpion TherapeuticsImvivaPerseo
Portfolio news
latest coverage across their companies
Optimeos-Logo-Web · finsmes.com · Jun 25, 2026
Azora Therapeutics · globenewswire.com · Jun 11, 2026
Frequently asked questions
- How many investments has 7G BioVentures made?
- 7G BioVentures has 18 tracked investments, including 1 dated in the last 24 months.
- What sectors does 7G BioVentures focus on?
- 7G BioVentures focuses on Biotech, Healthtech.
- Where is 7G BioVentures located?
- 7G BioVentures is headquartered in Burlingame, US.
- Who does 7G BioVentures co-invest with?
- 7G BioVentures most often shares deals with Beresford Ventures, Anzu Partners, Samsung Next, among 22 tracked co-investors.
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.